Soluble BTN2A1 as a potential predictive biomarker of immune checkpoint inhibitor efficacy in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Rochigneux, Philippe
Chretien, Anne Sophie
Rossille, Delphine
Chanez, Brice
Billon, Emilien
Fattori, Stephane
Corre, Romain
Pakradouni, Jihane
Goncalves, Anthony
Fest, Thierry
Madroszyk, Anne
Olive, Daniel
机构：
[1] Inst Paoli Calmettes, CRCM U1068, Marseille, France
[2] CRCM, Marseille, France
[3] Univ Hosp Rennes, Rennes, France
[4] Inst Paoli Calmette, Marseille, France
[5] Rennes Univ Hosp, Rennes, France
[6] Inst Paoli Calmettes, Dept Clin Res & Innovat, Marseille, France
[7] Aix Marseille Univ, Inst Paoli Calmettes, Dept Med Oncol, CRCM,CNRS,INSERM, Marseille, France
[8] Inst Paoli Calmettes CRCM U1068, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9561
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Minami, Daisuke
    Kudo, Kenichiro
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
    Robinson, Irina
    Hochmair, Maximilian Johannes
    Jansen, Christian
    Pacifico, Catia
    Sladek, Barbara
    Knabl, Alexander
    Gasche, Nikolaus
    Absenger, Gudrun
    Pichler, Martin
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 742 - 742
  • [43] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [44] EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON-SMALL CELL LUNG CANCER PATIENTS
    Okamatsu, Yuki
    Inoue, Shigesato
    Utsumi, Takahiro
    Kayukawa, Takafumi
    Uryu, Kazuyasu
    Inoue, Katsuhiro
    Tsubouchi, Kazuya
    Harada, Taishi
    RESPIROLOGY, 2018, 23 : 286 - 286
  • [45] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
    Mezquita, Laura
    Auclin, Edouard
    Ferrara, Roberto
    Charrier, Melinda
    Remon, Jordi
    Planchard, David
    Ponce, Santiago
    Paz Ares, Luis
    Leroy, Laura
    Audigier-Valette, Clarisse
    Felip, Enriqueta
    Zeron-Medina, Jorge
    Garrido, Pilar
    Brosseau, Solenn
    Zalcman, Gerard
    Mazieres, Julien
    Caramela, Caroline
    Lahmar, Jihene
    Adam, Julien
    Chaput, Nathalie
    Soria, Jean Charles
    Besse, Benjamin
    JAMA ONCOLOGY, 2018, 4 (03) : 351 - 357
  • [47] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
  • [48] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [49] The efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring driver mutations
    Sakamoto, Hiroaki
    Tanaka, Hisashi
    Shiratori, Toshihiro
    Baba, Keisuke
    Ishioka, Yoshiko
    Itoga, Masamichi
    Taima, Kageaki
    Hasegawa, Yukihiro
    Takanashi, Shingo
    Tasaka, Sadatomo
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (06) : 610 - 614
  • [50] Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations
    Wang, Haowei
    Cheng, Lei
    Zhao, Chao
    Zhou, Fei
    Jiang, Tao
    Guo, Haoyue
    Shi, Jinpeng
    Chen, Peixin
    Tang, Zhuoran
    Mao, Shiqi
    Jia, Keyi
    Ye, Lingyun
    Cai, Chenlei
    Li, Xuefei
    Chen, Xiaoxia
    Zhou, Caicun
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) : 219 - +
12345